STAR Apollo Mapping System
AI-powered cardiac mapping system for personalized atrial fibrillation treatment
Software · EmbeddedCompany source
Company profile
About Rhythm Al, Ltd
Rhythm AI, Ltd. is a medical technology company specializing in advanced cardiac mapping solutions for the treatment of atrial fibrillation (AF). The company's flagship product, the STAR Apollo Mapping System, leverages sophisticated artificial intelligence algorithms rooted in fundamental electrophysiological principles to transform how physicians diagnose and treat AF. The system integrates seamlessly with existing electrophysiology (EP) systems to provide cutting-edge, real-time data analysis that uncovers repetitive patterns of activation (RPAs) and identifies early sites of activation (ESAs) that are potential drivers of atrial fibrillation. This breakthrough capability empowers cardiologists and electrophysiologists to develop highly personalized treatment plans tailored to each patient's unique cardiac rhythm patterns. By focusing on understanding the underlying rhythm complexity, STAR Apollo enables physicians to create individual treatment strategies that go beyond traditional approaches. The system has received FDA clearance and is designed to integrate easily into current clinical workflows, allowing healthcare providers to enhance their AF ablation procedures without disrupting established practices. Rhythm AI's technology represents a significant advancement in cardiac electrophysiology, combining artificial intelligence with deep clinical expertise to improve outcomes for patients suffering from atrial fibrillation.
Company description Rhythm Al, Ltd official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Rhythm Al, Ltd?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Atrial Fibrillation
- Cardiac Arrhythmias
Who it serves
- Cardiac Electrophysiology Labs
- Health Systems
- Hospitals
Deployment & integration
Embedded deployment with recorded integration context.
Recorded integration context: CARTO 3 Mapping System.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance for commercial release version of STAR Apollo Mapping System. FDA clearance for updated system with CARTO 3 compatibility. Appointment of Mike Dineen as CEO. Live case demonstrations at AF Symposium 2026 and RIO Congress.
Partnerships
Recorded partners
- Baptist Health, Jacksonville, Florida
- Shifamed (portfolio company relationship)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
STAR Apollo Mapping SystemK220786 · 510k · Dec 1, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Personalized treatment plans
Enables physicians to craft highly personalized treatment plans tailored to each patient's unique needs
Identification of AF drivers
Pinpoints early sites of activation that are potential drivers of atrial fibrillation
Baptist Health, Jacksonville, Florida
Live case transmission and first-in-human cases using STAR Apollo Mapping System for atrial fibrillation treatment
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Rhythm Al, Ltd
Recent articles published on Rhythm Al, Ltd's official website.
RHYTHM AI announces FDA clearance for new STAR Apollo™ Mapping System
Read on Rhythm Al, LtdRHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo™ Mapping System
Read on Rhythm Al, LtdFDA clears RHYTHM AI’s new algorithm for atrial fibrillation
Read on Rhythm Al, LtdRHYTHM AI announces new STAR Apollo™ Mapping System to feature at Rhythm Interventions Online (RIO) Congress
Read on Rhythm Al, LtdRHYTHM AI’s STAR Apollo™ Mapping System to feature in live case transmission at AF Symposium 2026
Read on Rhythm Al, Ltd07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.